The importance of heart rate variability in predicting cardiac autonomic dysfunction in patients with amyotrophic lateral sclerosis

被引:9
作者
Iscan, Dilek [1 ]
Karaaslan, Muhammet Bugra [2 ]
Deveci, Onur Sinan [3 ]
Eker, Rabia Akili [3 ]
Koc, Filiz [4 ]
机构
[1] Aksaray Univ, Dept Neurol, Training & Res Hosp, TR-68200 Aksaray, Turkey
[2] Osmancik State Hosp, Dept Cardiol, Osmancik Corum, Turkey
[3] Cukurova Univ, Dept Cardiol, Fac Med, Saricam Adana, Turkey
[4] Cukurova Univ, Dept Neurol, Fac Med, Saricam Adana, Turkey
关键词
ALS;
D O I
10.1111/ijcp.14536
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim Amyotrophic lateral sclerosis (ALS) is a progressive disease characterized by degeneration in the upper and lower motor neurons of the corticospinal tract, brain stem, and spinal cord. Recent studies have revealed that the disease does not present solely with motor neuron involvement. Accordingly, the aim of this study is to investigate the presence of cardiac autonomic impairment in patients diagnosed with ALS. Material and Method A total of 61 patients, who were diagnosed with ALS according to the Revised El Escorial Criteria (R-EEC), were included in this prospective study, in addition to the 29 healthy individuals, who were included in the study as controls. In order to assess the cardiac autonomic involvement, the presence of orthostatic hypotension was investigated, and transthoracic echocardiography and 24-hour electrocardiogram (ECG) using a Holter monitor were performed. Results Orthostatic hypotension was detected in 14 (22.2%) patients. Holter electrocardiogram results of the patient group revealed statistically significantly lower heart rate variability (HRV) indicators in the time domain (SDNN, SDANN, SDNN index, rMSSD, and pNN50) and in the frequency domain (high frequency [HF], low frequency [LF], and very low frequency [VLF]) than those of the control group (P < .05). Conclusion Contrary to the popular opinion, cardiac autonomic dysfunction in patients with ALS can occur at any stage of the disease. Therefore, it is recommended that the patients are evaluated via periodic examinations during the follow-up period for cardiac autonomic involvement.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] A timeline for predicting durable medical equipment needs and interventions for amyotrophic lateral sclerosis patients
    Bromberg, Mark B.
    Brownell, Alexander A.
    Forshew, Dallas A.
    Swenson, Michael
    AMYOTROPHIC LATERAL SCLEROSIS, 2010, 11 (1-2): : 110 - 115
  • [42] Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it?
    De Marchi, Fabiola
    Carrarini, Claudia
    De Martino, Antonio
    Diamanti, Luca
    Fasano, Antonio
    Lupica, Antonino
    Russo, Mirella
    Salemme, Simone
    Spinelli, Edoardo Gioele
    Bombaci, Alessandro
    NEUROLOGICAL SCIENCES, 2021, 42 (06) : 2211 - 2222
  • [43] Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression
    Femiano, Cinzia
    Bruno, Antonio
    Gilio, Luana
    Buttari, Fabio
    Dolcetti, Ettore
    Galifi, Giovanni
    Azzolini, Federica
    Borrelli, Angela
    Furlan, Roberto
    Finardi, Annamaria
    Musella, Alessandra
    Mandolesi, Georgia
    Storto, Marianna
    Centonze, Diego
    Stampanoni Bassi, Mario
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [44] Magnetic source imaging of cortical dysfunction in amyotrophic lateral sclerosis
    Boyajian, Robert A.
    Arno, Carlos
    Otis, Shirley M.
    Romine, John S.
    Smith, Richard A.
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2008, 87 (06) : 427 - 437
  • [45] Optineurin dysfunction in amyotrophic lateral sclerosis: why so puzzling?
    Prtenjaca, Nikolina
    Dominovic, Marin
    Peradinovic, Josip
    Sajn, Rozalija
    Markovinovic, Andrea
    Munitic, Ivana
    PERIODICUM BIOLOGORUM, 2020, 121 (1-2) : 23 - 34
  • [46] Frontotemporal Dysfunction in Amyotrophic Lateral Sclerosis: A Discriminant Function Analysis
    Nidos, Andreas
    Kasselimis, Dimitrios S.
    Simos, Panagiotis G.
    Rentzos, Michael
    Alexakis, Theodoros
    Zalonis, Loannis
    Zouvelou, Vassiliki
    Potagas, Constantin
    Evdokimidis, Loannis
    Woolley, Susan C.
    NEURODEGENERATIVE DISEASES, 2016, 16 (3-4) : 140 - 146
  • [47] Differences in Dysfunction of Thenar and Hypothenar Motoneurons in Amyotrophic Lateral Sclerosis
    Fang, Jia
    Cui, Liying
    Liu, Mingsheng
    Guan, Yuzhou
    Li, Xiaoguang
    Li, Dawei
    Cui, Bo
    Shen, Dongchao
    Ding, Qingyun
    FRONTIERS IN HUMAN NEUROSCIENCE, 2016, 10
  • [48] Frontal lobe dysfunction in amyotrophic lateral sclerosis - A PET study
    Abrahams, S
    Goldstein, LH
    Kew, JJM
    Brooks, DJ
    Lloyd, CM
    Frith, CD
    Leigh, PN
    BRAIN, 1996, 119 : 2105 - 2120
  • [49] Increased prevalence of bladder and intestinal dysfunction in amyotrophic lateral sclerosis
    Nuebling, Georg S.
    Mie, Eva
    Bauer, Ricarda M.
    Hensler, Mira
    Lorenzl, Stefan
    Hapfelmeier, Alexander
    Irwin, Debra E.
    Borasio, Gian Domenico
    Winkler, Andrea S.
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2014, 15 (3-4) : 174 - 179
  • [50] Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it?
    Fabiola De Marchi
    Claudia Carrarini
    Antonio De Martino
    Luca Diamanti
    Antonio Fasano
    Antonino Lupica
    Mirella Russo
    Simone Salemme
    Edoardo Gioele Spinelli
    Alessandro Bombaci
    Neurological Sciences, 2021, 42 : 2211 - 2222